Literature DB >> 16103673

Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway.

Sven G Gehrke1, Thomas Herrmann, Hasan Kulaksiz, Uta Merle, Karin Bents, Iris Kaiser, Hans-Dieter Riedel, Wolfgang Stremmel.   

Abstract

BACKGROUND/AIMS: In HFE-related hereditary hemochromatosis an inappropriately low hepatic expression of the iron-regulatory peptide hepcidin (encoded by HAMP) has been suggested to cause iron overload. The aim of the present study was to evaluate whether the hepatic expression of HAMP in relation to iron stores requires HFE or might involve other important iron-related genes including HJV (encoding hemojuvelin) and TFR2 (encoding transferrin receptor-2).
METHODS: Using quantitative RT-PCR, the iron-dependent hepatic expression patterns of HAMP, HJV, and TFR2 were evaluated in human and murine HFE-related hemochromatosis.
RESULTS: The overall level of hepatic HAMP expression in human and murine HFE-related hemochromatosis is impaired but can still be modulated by iron stores. Moreover, we demonstrate an HFE-independent correlation between the expression of HAMP and TFR2 in mouse and human livers. On the other hand, a strong correlation between the hepatic expression of HAMP and HJV was only found in hemochromatosis patients and Hfe-deficient mice.
CONCLUSION: The central pathogenetic step in HFE-related hemochromatosis is an impaired basal expression of HAMP rather than a lack of HAMP upregulation in response to iron stores. An HFE-independent pathway that seems to involve TFR2 and HJV can regulate HAMP expression under conditions of iron overload. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103673     DOI: 10.1159/000087400

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  8 in total

1.  Repression of repulsive guidance molecule C during inflammation is independent of Hfe and involves tumor necrosis factor-alpha.

Authors:  Marco Constante; Dongmei Wang; Valérie-Ann Raymond; Marc Bilodeau; Manuela M Santos
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

2.  Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis.

Authors:  Elena Corradini; Cinzia Garuti; Giuliana Montosi; Paolo Ventura; Billy Andriopoulos; Herbert Y Lin; Antonello Pietrangelo; Jodie L Babitt
Journal:  Gastroenterology       Date:  2009-07-07       Impact factor: 22.682

3.  Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes.

Authors:  Guillemette Ramey; Jean-Christophe Deschemin; Sophie Vaulont
Journal:  Haematologica       Date:  2009-05-19       Impact factor: 9.941

Review 4.  Liver-gut axis in the regulation of iron homeostasis.

Authors:  Deepak Darshan; Gregory-J Anderson
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

5.  Relationship between gene expression of duodenal iron transporters and iron stores in hemochromatosis subjects.

Authors:  James E Nelson; Virginia R Mugford; Ellen Kilcourse; Richard S Wang; Kris V Kowdley
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11-05       Impact factor: 4.052

6.  Altered hepatic BMP signaling pathway in human HFE hemochromatosis.

Authors:  Giuliano Bolondi; Cinzia Garuti; Elena Corradini; Heinz Zoller; Wolfgang Vogel; Armin Finkenstedt; Jodie L Babitt; Herbert Y Lin; Antonello Pietrangelo
Journal:  Blood Cells Mol Dis       Date:  2010-09-21       Impact factor: 3.039

7.  Endofin, a novel BMP-SMAD regulator of the iron-regulatory hormone, hepcidin.

Authors:  Justin B Goh; Daniel F Wallace; Wanjin Hong; V Nathan Subramaniam
Journal:  Sci Rep       Date:  2015-09-11       Impact factor: 4.379

8.  In Absence of the Cellular Prion Protein, Alterations in Copper Metabolism and Copper-Dependent Oxidase Activity Affect Iron Distribution.

Authors:  Lisa Gasperini; Elisa Meneghetti; Giuseppe Legname; Federico Benetti
Journal:  Front Neurosci       Date:  2016-09-27       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.